KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash & Equivalents (2016 - 2026)

Zimmer Biomet Holdings has reported Cash & Equivalents over the past 18 years, most recently at $424.2 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 69.36% year-over-year to $424.2 million; the TTM value through Mar 2026 reached $424.2 million, down 69.36%, while the annual FY2025 figure was $591.9 million, 12.64% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $424.2 million at Zimmer Biomet Holdings, down from $591.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.4 billion in Q1 2025 and troughed at $292.1 million in Q3 2023.
  • A 5-year average of $544.6 million and a median of $424.2 million in 2026 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 252.29% in 2025 and later crashed 69.36% in 2026.
  • Year by year, Cash & Equivalents stood at $375.7 million in 2022, then increased by 10.67% to $415.8 million in 2023, then increased by 26.38% to $525.5 million in 2024, then increased by 12.64% to $591.9 million in 2025, then dropped by 28.33% to $424.2 million in 2026.
  • Business Quant data shows Cash & Equivalents for ZBH at $424.2 million in Q1 2026, $591.9 million in Q4 2025, and $1.3 billion in Q3 2025.